Nrc Health (NRC) Stock
Patient experience measurement provider for hospitals and clinics. Here's the price, business snapshot, and what's worth knowing about Nrc Health in August 2026.
National Research Corporation (NRC) is a US-based provider of patient experience measurement, analytics and market intelligence for healthcare organisations. Investors should know it operates in a specialised niche: helping hospitals, clinics and payers measure satisfaction, clinical outcomes and operational performance using surveys, software and consulting services. NRC’s revenue mix tends to include subscription-style services and professional fees, which can offer recurring income but also ties performance to healthcare budgets and client retention. Growth drivers include greater emphasis on patient-centred care, digital measurement tools and value-based reimbursement, while risks include competitive pressure, regulatory change, data-security obligations and small-cap volatility. With a market capitalisation around $279m, NRC is a smaller company where liquidity and earnings variability can be greater than for large-cap peers. This summary is for educational purposes only and not personal investment advice; prospective investors should review the company’s filings, consider their own risk tolerance and, if needed, consult a qualified adviser.
Sixth Month Growth Performance
Stock Performance Snapshot
Financial Health
National Research Corp shows strong revenue and profitability, indicating good financial performance overall.
Dividend
National Research Corp's dividend yield of 3% is reasonable for those interested in dividend-paying stocks. If you invested $1000 you would be paid $30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Patient Experience Focus
NRC’s core services measure patient satisfaction and outcomes — a growing priority for providers — though results can vary by contract mix and market.
Recurring Revenue Potential
Subscription-style analytics can give steady income and visibility, but performance depends on client retention and healthcare spending cycles.
Regulatory & Data Risk
Handling sensitive health data creates opportunities for value-added services but also exposes the firm to compliance, security and reputational risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
